Healthcare technology company Aktiia has received CE mark in Europe for its calibration-free technology CALFREE, which uses optical sensors in smartwatches and smartphone cameras to collect blood pressure data. This approval allows Aktiia to integrate its medical-grade optical blood pressure monitoring into third-party consumer devices, such as smartwatches and smartphones. Aktiia’s CEO believes this technology will revolutionize the wearable and mobile industry by enabling large-scale optical blood pressure monitoring and improving public health through better hypertension diagnosis and management. The Swiss company, founded in 2018, offers a wrist-worn optical blood pressure monitoring device that provides continuous analysis of various health metrics. They recently completed a $30 million funding round to further develop their technology.
Source link